Further analysis of the TCGA and GEPIA database revealed that among the 14 candidates, only the low expression of RBMS3 and CPEB4 were positively correlated with poor prognosis in glioma patients (Supplementary Fig. 1H, I). The gene discussed is RBMS3; the disease is central nervous system cancer.